CANAGLIFLOZIN

CANAGLIFLOZIN: Canagliflozin is a medication used to treat type 2 diabetes. It belongs to a class of drugs called sodium-glucose co-transporter 2 (SGLT2) inhibitors. This drug is prescribed in combination with diet and exercise to help control blood sugar levels.

The mechanism of action of canagliflozin involves inhibiting SGLT2 receptors in the kidneys. Normally, these receptors reabsorb glucose from the urine back into the bloodstream. By blocking this process, canagliflozin promotes the excretion of excess glucose in the urine, thus reducing blood sugar levels.

The typical starting dose of canagliflozin is 100 mg once daily, taken before the first meal of the day. It can be increased to 300 mg once daily if needed. However, the exact dosage may vary depending on individual needs and response to the medication. It is important to follow your doctor’s instructions regarding the dosage and timing of canagliflozin.

As with any medication, canagliflozin can have side effects. Common side effects include urinary tract infections, genital yeast infections, increased urination, increased thirst, and dehydration. It is crucial to drink plenty of fluids while taking canagliflozin to prevent dehydration. Some less common but serious side effects may include low blood sugar (hypoglycemia) when taken with other diabetes medications, kidney problems, or an increased risk of bone fractures.

It is important to consult your healthcare provider before starting canagliflozin to make sure it is suitable for your specific medical condition and to discuss the potential benefits and risks associated with this medication.